GoodRx Holdings
GDRX
159 hedge funds and large institutions have $853M invested in GoodRx Holdings in 2023 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 48 increasing their positions, 55 reducing their positions, and 21 closing their positions.
39% more call options, than puts
Call options by funds: $3.14M | Put options by funds: $2.27M
35% more capital invested
Capital invested by funds: $633M → $853M (+$220M)
10% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 21
0.45% more ownership
Funds ownership: 164.7% → 165.16% (+0.45%)
0% more funds holding
Funds holding: 159 → 159 (0)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
13% less repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 55
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$7.32M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$6.3M |
| 3 |
Goldman Sachs
New York
|
+$3.59M |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
+$3.58M |
| 5 |
AG
Algert Global
San Francisco,
California
|
+$3.13M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$14.1M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$9.92M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
-$5.06M |
| 4 |
Man Group
London,
United Kingdom
|
-$1.98M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.64M |
GDRX Hedge Fund Activity: Q1 2023 in Review
159 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in GoodRx Holdings (GDRX) for Q1 2023, worth a combined $853M — up 35% from $633M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new GDRX positions and 21 closed out — a net gain of 2 holders — while 48 added to existing stakes and 55 trimmed.
The largest buyer was OrbiMed, adding an estimated $7.32M. The largest seller was Millennium Management, cutting an estimated $14.1M.
- 159 institutional investors held GoodRx Holdings (GDRX) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $853M of GoodRx Holdings stock for Q1 2023, up 35% quarter-over-quarter.
- 23 funds opened new GoodRx Holdings positions in Q1 2023 and 21 closed out, a net change of +2 holders.
- The largest GoodRx Holdings buyer in Q1 2023 was OrbiMed, an estimated $7.32M added.
- The largest GoodRx Holdings seller in Q1 2023 was Millennium Management, an estimated $14.1M sold.
Based on aggregated 13F filings for Q1 2023.